| Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer DJ Pinato, A Zambelli, J Aguilar-Company, M Bower, CCT Sng, R Salazar, ... Cancer discovery 10 (10), 1465-1474, 2020 | 178 | 2020 |
| Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective … DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ... The Lancet Oncology 22 (12), 1669-1680, 2021 | 125 | 2021 |
| Exposure to glyphosate-and/or Mn/Zn-ethylene-bis-dithiocarbamate-containing pesticides leads to degeneration of γ-aminobutyric acid and dopamine neurons in Caenorhabditis elegans R Negga, JA Stuart, ML Machen, J Salva, AJ Lizek, SJ Richardson, ... Neurotoxicity research 21, 281-290, 2012 | 98 | 2012 |
| Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre … DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ... The Lancet Oncology 23 (7), 865-875, 2022 | 60 | 2022 |
| Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score GM Dettorre, S Dolly, A Loizidou, J Chester, A Jackson, U Mukherjee, ... Journal for ImmunoTherapy of Cancer 9 (3), 2021 | 44 | 2021 |
| Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study DJ Pinato, L Scotti, A Gennari, E Colomba-Blameble, S Dolly, A Loizidou, ... European Journal of Cancer 150, 190-202, 2021 | 43 | 2021 |
| Combined treatment with immunotherapy-based strategies for MSS metastatic colorectal cancer I Baraibar, O Mirallas, N Saoudi, J Ros, F Salvà, J Tabernero, E Élez Cancers 13 (24), 6311, 2021 | 39 | 2021 |
| Modification of BRCA1-associated breast cancer risk by HMMR overexpression F Mateo, Z He, L Mei, GR de Garibay, C Herranz, N García, A Lorentzian, ... Nature communications 13 (1), 1895, 2022 | 31 | 2022 |
| The postpartum telogen effluvium fallacy O Mirallas, R Grimalt Skin Appendage Disorders 1 (4), 198-201, 2016 | 26 | 2016 |
| Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer DJ Pinato, D Ferrante, J Aguilar-Company, M Bower, R Salazar, ... European Journal of Cancer 171, 64-74, 2022 | 24 | 2022 |
| COVID-19 sequelae and the host proinflammatory response: an analysis from the OnCovid registry A Cortellini, A Gennari, F Pommeret, G Patel, T Newsom-Davis, A Bertuzzi, ... JNCI: Journal of the National Cancer Institute 114 (7), 979-987, 2022 | 22 | 2022 |
| SARS-CoV-2 omicron (B. 1.1. 529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry A Cortellini, J Tabernero, U Mukherjee, R Salazar, A Sureda, C Maluquer, ... The Lancet Oncology 24 (4), 335-346, 2023 | 20 | 2023 |
| Advances in immunotherapy for cervical cancer JF Grau-Bejar, C Garcia-Duran, D Garcia-Illescas, O Mirallas, A Oaknin Therapeutic Advances in Medical Oncology 15, 17588359231163836, 2023 | 18 | 2023 |
| Advances in the systemic treatment of therapeutic approaches in biliary tract cancer O Mirallas, D López-Valbuena, D García-Illescas, C Fabregat-Franco, ... ESMO open 7 (3), 100503, 2022 | 14 | 2022 |
| Pandemic phase-adjusted analysis of COVID-19 outcomes reveals reduced intrinsic vulnerability and substantial vaccine protection from severe acute respiratory syndrome … M Tagliamento, A Gennari, M Lambertini, R Salazar, N Harbeck, ... Journal of Clinical Oncology 41 (15), 2800-2814, 2023 | 12 | 2023 |
| CDK-mediated Yku80 phosphorylation regulates the balance between non-homologous end joining (NHEJ) and homologous directed recombination (HDR) R Carballar, JM Martínez-Láinez, B Samper, S Bru, E Bállega, O Mirallas, ... Journal of Molecular Biology 432 (24), 166715, 2020 | 10 | 2020 |
| Intertwined control of the cell cycle and nucleocytoplasmic transport by the cyclin-dependent kinase Pho85 and RanGTPase Gsp1 in Saccharomyces cerevisiae O Mirallas, E Ballega, B Samper-Martín, S García-Márquez, R Carballar, ... Microbiological research 206, 168-176, 2018 | 8 | 2018 |
| A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials A Hernando-Calvo, M Vila-Casadesus, Y Bareche, A Gonzalez-Medina, ... Med 4 (10), 710-727. e5, 2023 | 6 | 2023 |
| 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection A Cortellini, E Roldán, MCC Garcia, R Berardi, A Sánchez, C Martinez, ... Annals of Oncology 32, S1130, 2021 | 6 | 2021 |
| Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients A Hernando-Calvo, O Mirallas, D Marmolejo, O Saavedra, M Vieito, ... Oral Oncology 140, 106364, 2023 | 5 | 2023 |
